.Pharmacolibrary.Drugs.S_SensoryOrgans.S01F_MydriaticsAndCycloplegics.S01FA01_Atropine.Atropine .Pharmacolibrary.Drugs.S_SensoryOrgans.S01F_MydriaticsAndCycloplegics.S01FA01_Atropine.Atropine| name: | Atropine |
| ATC code: | S01FA01 | route: | intravenous |
| n-compartments | 2 |
Atropine is a competitive antagonist of the muscarinic acetylcholine receptors. It is used clinically to treat bradycardia, organophosphate poisoning, and as a pre-anesthetic to reduce salivation. Atropine remains an approved and widely used medication in current medical practice.
Pharmacokinetic parameters reported in healthy adult individuals after intravenous administration.
Ström, L, et al., & Ekstrand, C (2021). Topical ophthalmic atropine in horses, pharmacokinetics and effect on intestinal motility. BMC veterinary research 17(1) 149–None. DOI:10.1186/s12917-021-02847-4 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33827566
Sjödin, L, et al., & Al-Saffar, A (2011). Using pharmacokinetic modeling to determine the effect of drug and food on gastrointestinal transit in dogs. Journal of pharmacological and toxicological methods 64(1) 42–52. DOI:10.1016/j.vascn.2011.04.008 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21596146
Miyabe-Nishiwaki, T, et al., & Kanazawa, H (2013). Evaluation of the predictive performance of a pharmacokinetic model for propofol in Japanese macaques (Macaca fuscata fuscata). Journal of veterinary pharmacology and therapeutics 36(2) 169–173. DOI:10.1111/j.1365-2885.2012.01404.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/22568878